NTRA News and Press, Natera Inc. From 05/04/20

SAN CARLOS, Calif. , May 4, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the achievement of key recruitment milestones in the ProActive registry study and success in the Prospera early access program.&#...

Warren Buffett will issue his annual letter and hold a virtual shareholder meeting ( BRK.A , BRK.B ) this Saturday, 5/2. More news on: Berkshire Hathaway Inc., Berkshire Hathaway Inc., BridgeBio Pharma, Inc., Notable Calls, , Read more ...

SAN CARLOS, Calif. , April 29, 2020 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2020 , after the market close on May 6, 2020 . Natera will h...

Natera ( NTRA ) has emerged as a rapidly growing company with seven commercialized molecular diagnostic tests targeting key markets of reproductive health, organ transplantation, and oncology. The company enjoys a leadership position in the reproductive health segment, which is almost entirely...

CareDx ( CDNA ) is a precision medicine company focused on the ever-growing transplant diagnostics market. The ongoing COVID-19 pandemic has had a significant negative impact on the stock. The stock fell from $21.15 on January 2 all the way down to $13.94 on March 18. The stock has recovered a...

SAN CARLOS, Calif. , April 15, 2020 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today asserted three recently issued oncology patents against ArcherDX in its ongoing patent infringement action filed in the U.S. District Court...

SAN CARLOS, Calif. , April 13, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) today announced that it has priced $250 million aggregate principal amount of convertible senior notes due 2027 (the "notes"). The notes will be sold to qualified institutional buyers pursuant to Rule 144A...

Citing COVID-19 disruptions, Natera (NASDAQ: NTRA ) is withdrawing its financial guidance for the 2020 fiscal year. More news on: Natera, Inc., Healthcare stocks news, , Read more ...

SAN CARLOS, Calif. , April 13, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA) today announced that it proposes to offer $250 million aggregate principal amount of convertible senior notes due 2027 (the "notes"), subject to market conditions and other factors. The notes are...

SAN CARLOS, Calif. , April 13, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced preliminary operational and financial results for the quarter ended March 31 , 2020. Natera generated total revenue...